Entry Inhibitors in Development

Effect of Rifampicin on BMS-663068 in Healthy Volunteers (May/June 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
An Overview of INCB-9471 (May 29, 2013)
From AIDSinfo
An Overview of AMD-070 (May 29, 2013)
From AIDSinfo
An Overview of PRO-140 (May 29, 2013)
From AIDSinfo
An Overview of Ibalizumab (May 29, 2013)
From AIDSinfo
An Overview of Cenicriviroc (May 29, 2013)
From AIDSinfo
An Overview of BMS-663068 (May 29, 2013)
From AIDSinfo
ARV Pipeline: Dolutegravir, TAF (GS-7340), MK-1439 and Cenicriviroc (March/April 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
CCR5/CCR2 Antagonist Cenicriviroc: 24-Week Data vs. Efavirenz in ART-Naive (March 8, 2013)
From National AIDS Treatment Advocacy Project
New Drug Hits HIV and Inflammatory Processes (March 7, 2013)
From MedPage Today

VIEW ALL ARTICLES

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

New! TheBody.com's App
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.